Cleared Special

K161021 - HydroMARK Breast Biopsy Site Marker

K161021 is the FDA 510(k) clearance for HydroMARK Breast Biopsy Site Marker by Devicor Medical Products, Inc.. It is a Class 2 General & Plastic Surgery device (product code NEU) cleared through the Special 510(k) pathway after a 23-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2016
Decision
23d
Days
Class 2
Risk

K161021 is an FDA 510(k) clearance for the HydroMARK Breast Biopsy Site Marker. Classified as Marker, Radiographic, Implantable (product code NEU), Class II - Special Controls.

Submitted by Devicor Medical Products, Inc. (Cincinnati, US). The FDA issued a Cleared decision on May 5, 2016 after a review of 23 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4300 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Devicor Medical Products, Inc. devices

Submission Details

510(k) Number K161021 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2016
Decision Date May 05, 2016
Days to Decision 23 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 115d · This submission: 23d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NEU Marker, Radiographic, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - NEU Marker, Radiographic, Implantable

All 56
Devices cleared under the same product code (NEU) and FDA review panel - the closest regulatory comparables to K161021.
Tumark Vision
K180443 · Somatex Medical Technologies GmbH · Mar 2018
UltraCor Twirl Breast Tissue Marker
K180061 · Bard Peripheral Vascular, Inc. · Mar 2018
Magseed Magnetic Marker Systtem
K173587 · Endomagnetics Ltd., · Feb 2018
Beacon Fine Needle Fiducial System
K152586 · Covidien, LLC · Dec 2015
BNX Fine Needle Aspiration System
K142198 · Covidien, LLC · Oct 2014
ECHO TIP ULTRA FIDUCIAL NEEDLE
K141356 · Wilson-Cook Medical, Inc. · Jun 2014